MINNEAPOLIS, July 28, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (the “Company”), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today ...
ARLINGTON, Va.--(BUSINESS WIRE)--AeroVironment, Inc. (NASDAQ: AVAV) (the “Company”) today announced the pricing of its upsized underwritten public offering of 3,528,226 shares of its common stock (the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback